Bachem Holding AG (SWX:BANB)

SpringWorks Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.14	95.2	157.73	31.45	89.19	23.5
Short-Term Investments	-	-	140.8	236.98	353.17	-
Cash & Short-Term Investments	29.14	95.2	298.53	268.43	442.36	23.5
Cash Growth	-83.18%	-68.11%	11.21%	-39.32%	1782.69%	9.64%
Accounts Receivable	174.11	240.49	176.1	171.04	106.49	76.34
Other Receivables	10.07	15.51	7.45	8.22	8.33	4.6
Receivables	184.19	256	183.56	179.26	114.82	80.94
Inventory	482.88	450.16	340.99	308.05	272.35	245.24
Prepaid Expenses	14.39	21.44	18.46	4.69	4.14	2.8
Total Current Assets	710.6	822.79	841.53	760.42	833.67	352.47
Property, Plant & Equipment	1,161	1,063	814.55	599.79	445.72	340.29
Other Intangible Assets	23.05	21.5	13.96	13.82	13.4	13.32
Long-Term Deferred Tax Assets	16.33	15.38	12.84	9.52	5.38	4.42
Long-Term Deferred Charges	-	-	-	-	-	0.07
Other Long-Term Assets	-	-	-	0.32	0.32	0.32
Total Assets	1,911	1,923	1,683	1,384	1,298	710.88
Accounts Payable	32.21	72.93	29.09	32.07	25.03	25.53
Accrued Expenses	44.99	46.96	45.78	37.75	34.62	26.9
Short-Term Debt	60.7	-	-	-	20	47.3
Current Portion of Leases	0.06	0.16	0.18	0.34	0.36	0.11
Current Income Taxes Payable	11.71	13.33	13.59	11.13	2.21	3.78
Current Unearned Revenue	102.6	93.42	29.66	38.17	-	-
Other Current Liabilities	39.28	54.19	46.42	45.31	52.33	33.88
Total Current Liabilities	291.56	280.99	164.72	164.78	134.56	137.49
Long-Term Debt	-	-	-	-	-	60
Long-Term Leases	0.1	0.13	0.22	0.35	0.5	0.14
Long-Term Unearned Revenue	201.28	192.99	145.56	-	-	-
Long-Term Deferred Tax Liabilities	57.87	57.78	51.86	49.08	42.44	37.54
Total Liabilities	550.82	531.88	362.36	214.21	177.5	235.17
Common Stock	0.75	0.75	0.75	0.74	0.74	0.7
Additional Paid-In Capital	602.04	633.56	662.82	583.89	609.6	59.31
Retained Earnings	819.84	801.98	711.73	628.36	552.14	460.27
Treasury Stock	-2.04	-2.07	-1.82	-1.96	-1.17	-1
Comprehensive Income & Other	-60.59	-43.12	-52.95	-41.37	-40.3	-43.56
Shareholders' Equity	1,360	1,391	1,321	1,170	1,121	475.71
Total Liabilities & Equity	1,911	1,923	1,683	1,384	1,298	710.88
Total Debt	60.87	0.29	0.4	0.69	20.86	107.55
Net Cash (Debt)	-31.73	94.91	298.13	267.74	421.49	-84.06
Net Cash Growth	-	-68.16%	11.35%	-36.48%	-	-
Net Cash Per Share	-0.42	1.27	3.99	3.63	5.95	-1.20
Filing Date Shares Outstanding	74.78	74.97	74.97	73.72	73.73	69.98
Total Common Shares Outstanding	74.78	74.97	74.97	73.72	73.73	69.98
Working Capital	419.04	541.8	676.81	595.64	699.11	214.98
Book Value Per Share	18.19	18.55	17.61	15.87	15.20	6.80
Tangible Book Value	1,337	1,370	1,307	1,156	1,108	462.4
Tangible Book Value Per Share	17.88	18.27	17.43	15.68	15.02	6.61
Land	-	402.62	327.44	296.26	244.71	210.5
Machinery	-	489.31	423.41	415.94	383.15	339.67
Construction In Progress	-	510.15	372.37	193.38	103.03	56.74

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.